Dermatologicals in Indonesia

September 2023 | 22 pages | ID: DAFF4A8B556EN
Euromonitor International Ltd

Abstracts

In Indonesia, according to data from the Indonesian Paediatrician Association (IDAI), around 7-35% of babies aged 6-12 months experience nappy (diaper) rash. With Indonesia’s population, that means between two million and 10 million babies suffer from nappy (diaper) rash. The pH level of babies’ skin is higher than that of adults, and it dries out more readily. This is what encourages the growth of harmful bacteria, and babies are therefore susceptible to nappy (diaper) rash. This is expected to...

Euromonitor International's Dermatologicals in Indonesia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Dermatologicals market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Dermatologicals in Indonesia
Euromonitor International
September 2023

LIST OF CONTENTS AND TABLES

DERMATOLOGICALS IN INDONESIA
KEY DATA FINDINGS

2023 DEVELOPMENTS

Millions of babies experience nappy rash, driving sales of treatments
Although store-based retail maintains its dominance, e-commerce continues to rise
Strengthening competition in topical germicidals/antiseptics
PROSPECTS AND OPPORTUNITIES
Continued growth expected, due partly to the weather conditions
Risk of candida auris fungus in Indonesia, which will drive sales of topical antifungals
Increasing number of uses set to drive growth for nappy (diaper) rash treatments
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2018-2023
Table 2 Sales of Dermatologicals by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Dermatologicals: % Value 2019-2023
Table 4 LBN Brand Shares of Dermatologicals: % Value 2020-2023
Table 5 Forecast Sales of Dermatologicals by Category: Value 2023-2028
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN INDONESIA
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture

2023 KEY TRENDS

Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2018-2023
Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 13 Distribution of Consumer Health by Format: % Value 2018-2023
Table 14 Distribution of Consumer Health by Format and Category: % Value 2023
Table 15 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources